X0306 4 2020-10-11 0 0001636651 Ovid Therapeutics Inc. OVID 0001704660 Haasner Dirk C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036 0 1 0 0 SVP, Global Regulatory Affairs Stock option (Right to Buy) 5.65 2020-10-11 4 A 0 20000 0.00 A 2030-10-10 Common Stock 20000 20000 D 50% of the shares subject to the Stock Option will vest and become exercisable on October 11, 2021 and the remaining shares will vest in 12 equal installments thereafter, subject to the Reporting Person's continued service through each such date. /s/ Danielle Mann for Dirk Haasner by PoA 2020-10-13